Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03876769
Title Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients (CASSIOPEIA)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

B-cell acute lymphoblastic leukemia

Therapies

Tisagenlecleucel

Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.